OBIO EXECUTIVE EXCHANGE SERIES: OPTIMIZING CLINICAL STATEGIES TO DRIVE REIMBURSEMENT

Understand the importance of developing your clinical strategy early in the drug development process. This exclusive workshop is focused on Canadian and International Reimbursement Strategies and will be lead by Allan Miranda, Therapeutic Lead, Reimbursement and Market Access, and Lois Mitchell, Director, New Product Development with Janssen Pharmaceutical Companies of Johnson & Johnson.